Imugene Limited's (ASX:IMU) (OTCMKTS:IUGNF) Leslie Chong caught up with Proactive's Andrew Scott following the news California-based investment bank Roth Capital Partners has initiated coverage with a Buy rating and a 12-month price target of 13 cents. She says it's a great accomplishment for them to be told they're a buy and that's only on three of their compounds.
viewImugene Limited
(
ASX:IMUOTC:IUGNF
)
Imugene's Leslie Chong says Roth Capital Partners' report is 'great accomplishment'
Quick facts: Imugene Limited
Follow
ASX:IMU
Price: 0.505 AUD
Market Cap: $2.73 billion
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
Imugene ends June 2021 quarter with $29.5m cash balance and strong...
Most read
Mining
Lake Resources halted pending news on material agreement with technology partner
3 days, 21 hours ago
